Pharma BD Deal Intelligence
Shire plc / New River Pharmaceuticals Inc.
2007 · Acquisition/Merger · $2.6B · Complete
Announcement Sentiment
88
Strongly positive
$64/share, ~$2.6B all-cash. Vyvanse (lisdexamfetamine) ADHD prodrug. Source: SEC, Shire/NRP press release, PharmaTimes.
Key facts
- Announced Feb 20, 2007
- Deal value $2.6B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals